154 related articles for article (PubMed ID: 12834454)
1. Cutaneous extranasal NK/T-cell lymphoma.
Ruiz Villaverde R; Blasco Melguizo J; Juez Martel I; Linares Solano J; Naranjo Sintes R
J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):434-6. PubMed ID: 12834454
[TBL] [Abstract][Full Text] [Related]
2. Nasal natural killer/T cell lymphoma with cutaneous involvement: case report and Chinese literature review reported in China mainland.
Liu J; He Z; Xie Y; Fang K; Gao Z; Wang B
J Dermatol; 2003 Oct; 30(10):735-41. PubMed ID: 14684957
[TBL] [Abstract][Full Text] [Related]
3. Localized cutaneous T cell lymphoma presenting as disfiguring facial lesions.
Kaliyadan F; Jayasree MG; Unni M; Neeraj S
Dermatol Online J; 2009 Nov; 15(11):14. PubMed ID: 19951650
[No Abstract] [Full Text] [Related]
4. Cutaneous natural killer/T-cell lymphoma.
Radonich MA; Lazova R; Bolognia J
J Am Acad Dermatol; 2002 Mar; 46(3):451-6. PubMed ID: 11862188
[TBL] [Abstract][Full Text] [Related]
5. Extra nodal NK/T-cell lymphoma nasal type that responded to DeVIC combination chemotherapy.
Nomura E; Isoda K; Yamanaka K; Yamaguchi M; Hakamada A; Mizutani H
J Dermatol; 2005 Mar; 32(3):204-9. PubMed ID: 15863868
[TBL] [Abstract][Full Text] [Related]
6. Testicular lymphoma: a literature review and report of a case with a zoster-like cutaneous recurrence.
Ingram RM; Williams ME; Fintel WA; Ross M
Clin Lymphoma; 2002 Mar; 2(4):238-41. PubMed ID: 11970763
[TBL] [Abstract][Full Text] [Related]
7. Management of primary cutaneous CD4
Yuan Z; Grass GD; Robinson TJ; Kim S
J Am Acad Dermatol; 2018 Oct; 79(4):772-774. PubMed ID: 29857014
[No Abstract] [Full Text] [Related]
8. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a case report.
Wang P; Wang Z; Kong Y; Xu A
Int J Dermatol; 2009 Jan; 48(1):62-5. PubMed ID: 19126053
[No Abstract] [Full Text] [Related]
9. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinicopathologic analysis of cutaneous peripheral T-cell lymphoma, not otherwise specified, according to primary tumor site.
Lee MH; Choi ME; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
J Am Acad Dermatol; 2019 Jun; 80(6):1771-1774. PubMed ID: 30296539
[No Abstract] [Full Text] [Related]
12. A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature.
Stokkermans-Dubois J; Jouary T; Vergier B; Delaunay MM; Taieb A
Dermatology; 2006; 213(4):345-9. PubMed ID: 17135744
[TBL] [Abstract][Full Text] [Related]
13. Management of cutaneous T-cell lymphoma.
Duhovic C; Child F; Wain EM
Clin Med (Lond); 2012 Apr; 12(2):160-4. PubMed ID: 22586794
[No Abstract] [Full Text] [Related]
14. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
15. CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
Lan MX; Zhen ZX; Ming WH
Leuk Lymphoma; 2009 Oct; 50(10):1715-7. PubMed ID: 19863343
[No Abstract] [Full Text] [Related]
16. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
[No Abstract] [Full Text] [Related]
17. Nasal and nasal-type natural killer/T-cell lymphoma.
Hirakawa S; Kuyama M; Takahashi S; Yamasaki O; Kanzaki H; Teshima T; Harada M; Ma Y; Kawabata T; Yoshino T; Arata J
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):268-72. PubMed ID: 10025761
[TBL] [Abstract][Full Text] [Related]
18. Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphoma.
Shapiro M; Rook AH; Lehrer MS; Junkins-Hopkins JM; French LE; Vittorio CC
J Am Acad Dermatol; 2002 Dec; 47(6):956-61. PubMed ID: 12451388
[No Abstract] [Full Text] [Related]
19. Primary cutaneous T-cell lymphoma localized to the lower leg: a distinct, locally aggressive cutaneous T-cell lymphoma.
Poligone B; Wilson LD; Subtil A; Heald P
Arch Dermatol; 2009 Jun; 145(6):677-82. PubMed ID: 19528423
[TBL] [Abstract][Full Text] [Related]
20. Management of the primary cutaneous lymphomas.
Prince HM; McCormack C; Ryan G; O'Keefe R; Seymour JF; Baker C
Australas J Dermatol; 2003 Nov; 44(4):227-40; quiz 241-2. PubMed ID: 14616487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
